Monitoring Movement Disorder Symptoms With a Mobile Medical App on Off-the-shelf Consumer Mobile Devices

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05680961

Enrollment

100

Registered

2023-01-11

Start date

2019-01-19

Completion date

2023-08-01

Last updated

2023-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Parkinson's disease

Brief summary

The purpose of this study is to evaluate whether New Touch Digital (NTD) NeuroRPM software installed on wearable devices can objectively measure and track symptoms in patients with Parkinson's disease.

Interventions

DEVICEMonitoring Device

Monitoring Device

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Subject is 18 years of age or older 2. Subject is able to provide informed written consent 3. Subject has been clinically diagnosed with Parkinson's Disease 4. Subject is mentally and physically capable of performing tasks on the mobile device and related physical activities herein described

Exclusion criteria

1. Inability to give informed consent 2. Presence of additional neurological disease aside from the diseases being studied 3. Inability to understand and follow the directions for the study

Design outcomes

Primary

Measure	Time frame	Description
NeuroRPM UPDRS predicted score vs. clinical raters' UPDRS	Comparison will be performed upon completion of the study, approximately in 1 year.	We will compare symptom severity as predicted by NeuroRPM to UPDRS scores from clinical raters. Statistical significance will be evaluated by intraclass correlation and kappa-statistic.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026